dm+d

108473005

Articles

Safety in Lactation: Dopaminergic drugs used in Parkinsons disease

25 September 2020Although rare, Parkinson’s disease can occur in younger women of childbearing age. Dopamine receptor agonists are used either alone or as an adjunct to levodopa…
Search Articles

Medicine Compliance Aid Stability

RequipGlaxoSmithKline UK

GlaxoSmithKline UK
Requip
Tablets f/c 0.25mg, 0.5mg, 1mg, 2mg, 5mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from light
Protect from moisture
Protect from moisture and light.
12 October 2015

Requip XLGlaxoSmithKline UK

GlaxoSmithKline UK
Requip XL
Tablets m/r f/c 2mg, 4mg, 8mg
A2 · Amber 2No stability data is available, the manufacturer does not, or cannot recommend use in CAs but there are no theoretical concerns with the product.
No special precautions for storage
No special precautions for storage.
12 October 2015

AdartrelGlaxoSmithKline UK

GlaxoSmithKline UK
Adartrel
Tablets f/c 250 micrograms, 500 microgram, 2mg
A2 · Amber 2No stability data is available, the manufacturer does not, or cannot recommend use in CAs but there are no theoretical concerns with the product.
No special precautions for storage
No special requirements for storage.
12 October 2015

genericActavis UK Ltd

Actavis UK Ltd
generic
Tablets f/c 250 micrograms, 500 microgram, 1mg, 2mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from light
Protect from light. More information may be available from manufacturer on a case-by-case basis.
12 October 2015

Raponer XLActavis UK Ltd

Actavis UK Ltd
Raponer XL
Tablets m/r 2mg, 4mg, 6mg , 8mg
A2 · Amber 2No stability data is available, the manufacturer does not, or cannot recommend use in CAs but there are no theoretical concerns with the product.
No special requirements for storage.
12 October 2015

Lactation Safety Information

No
Levodopa, (as co-beneldopa or co-careldopa)
May interfere with lactation
No published evidence of safety
Dopamine receptor agonist
25 June 2021